Evidence mapPaperPMID 42466199Full record

ArticleClinical kidney journal2026

Global trends and projections of early-onset CKD burden: a GBD 2021 analysis.

Ailing Chen, Yuwei Liu, Xiaohu Chen, Chunyi Zhang, Li Wang, Chaoyan Yue

Abstract read
In one paragraph

Article in Clinical kidney journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ailing ChenDepartment of Obstetrics and Gynecology, Women's Hospital of Jiangnan University, Wuxi Maternity and Child Health Care Hospital, Wuxi, China.
Yuwei LiuThe School of Life Sciences and Technology, Tongji University, Shanghai, China.
Xiaohu ChenObstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Shanghai, China.
Chunyi ZhangObstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Shanghai, China.
Li WangDepartment of Neonatology, XinHua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
Chaoyan YueObstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chronic kidney disease (CKD) is a major global health concern. While adult CKD has been widely studied, systematic evaluation of early-onset CKD (ages 0-25) remains limited. Using Global Burden of Disease 2021 data, this study provides the first comprehensive assessment of early-onset CKD burden from 1990 to 2021 to inform prevention and control strategies. Methods: We analyzed age-standardized incidence, mortality, prevalence, and disability-adjusted life years (DALYs) among individuals aged 0-25 across Socio-demographic Index (SDI) quintiles. Temporal trends were quantified using segmented regression and average annual percentage change. Cross-country inequalities were measured via slope and concentration indices. Bayesian Age-Period-Cohort models projected burden through 2050. Das Gupta decomposition assessed contributions from population growth, aging, and epidemiologic shifts. Frontier analysis examined the relationship between SDI and DALYs to estimate preventable burden. Results: Early-onset CKD demonstrated divergent global patterns: mortality declined [estimated annual percentage change (EAPC) -0.87%] while incidence increased (EAPC 0.31%). Total cases rose to 41.79 million (EAPC 0.13%), whereas DALYs fell to 3.32 million (EAPC -0.89%). Mortality reductions were greatest in medium/low SDI regions, but incidence increases were also most pronounced there. SDI was inversely associated with mortality. Age patterns showed bimodal peaks: children under 5 (45.58% of new cases) and young adults 20-24 years (32.32% of DALYs), with higher male mortality in the latter group. Unknown etiologies dominated (58%-68%), followed by glomerulonephritis; in East Asia, type 1 diabetes accounted for 20.42% of deaths. Frontier analysis indicated limited prevention efficiency in low SDI settings and untapped potential in high SDI regions. Conclusions: Early-onset CKD showed declining mortality but rising incidence, likely reflecting improved survival, better ascertainment, and persistent risk exposures. Reducing this burden will require targeted action on SDI-related disparities, the high proportion of unknown etiology, and the shifting burden across childhood and young adulthood. In the context of the 2025 World Health Organization resolution integrating kidney health into the global noncommunicable disease agenda, these findings support stronger surveillance, early detection, and equitable resource allocation for younger populations.

Indexed as

0 to 25 yearsearly-onset chronic kidney diseaseglobal burden of diseasesocio-demographic indextrend analysis

Identifiers

PMID42466199
PMCPMC13373965

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.